









Markets
/
Stocks
/
nasdaq-tsbx
/

Turnstone Biologics Corp

TSBX

0.355USD

0.000

Close 12/24, 13:00（ET）Quotes delayed by 15 min

8.21MMarket Cap

LossP/E TTM



Turnstone Biologics Corp

0.355

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Turnstone Biologics Corp to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

72.97%-4.30M

59.39%-7.09M

-6.27%-16.48M

6.44%-17.58M

-8.40%-15.93M

-1.69%-17.46M

---15.50M

---18.79M

---14.69M

-4.35%-17.17M

---16.45M

Net income from continuing operations

74.23%-5.49M

39.85%-11.81M

21.75%-12.87M

1.66%-17.03M

0.91%-21.30M

-28966.18%-19.63M

---16.45M

---17.32M

---21.50M

100.54%68.00K

---12.62M

Operating gains losses

-100.00%0.00

-40.86%301.00K

-84.96%337.00K

-29.86%491.00K

-31.78%498.00K

-28.21%509.00K

--2.24M

--700.00K

--730.00K

-0.28%709.00K

--711.00K

Deferred tax

----

---23.00K

--1.00K

---1.00K

--23.00K

--0.00

Other non-cash items

82.93%-92.00K

----

66.05%-880.00K

-326.50%-530.00K

-1200.00%-539.00K

-305.57%-738.00K

---2.59M

--234.00K

--49.00K

-21.10%359.00K

--455.00K

Change in working capital

-82.40%771.00K

28.57%1.76M

-1934.62%-4.29M

62.86%-1.41M

-11.17%4.38M

107.12%1.37M

--234.00K

---3.81M

--4.93M

-223.16%-19.28M

---5.97M

-Change in receivables

----

-100.00%0.00

-95.43%194.00K

--23.00K

--33.00K

--4.23M

396.49%4.25M

--855.00K

-Change in prepaid expenses

-23.08%860.00K

1608.70%1.96M

-68.58%521.00K

91.28%-257.00K

22.32%1.12M

143.89%115.00K

--1.66M

---2.95M

--914.00K

80.52%-262.00K

---1.34M

-Change in other current assets

602.40%878.00K

-7.42%399.00K

106.67%124.00K

296.00%495.00K

120.10%125.00K

--431.00K

--60.00K

--125.00K

---622.00K

----

-Change in other current liabilities

----

2166.67%204.00K

----

--0.00

100.00%0.00

--9.00K

---188.00K

--0.00

-323.59%-20.59M

---4.86M

Cash from non-recurring investing activities

Cash from operating activities

72.97%-4.30M

59.39%-7.09M

-6.27%-16.48M

6.44%-17.58M

-8.40%-15.93M

-1.69%-17.46M

---15.50M

---18.79M

---14.69M

-4.35%-17.17M

---16.45M

Investing cash flow

Net cash from continuing investing activities

-1268.75%-935.00K

-108.33%-12.00K

93.01%-19.00K

-100.37%-1.00K

70.21%80.00K

-80.80%144.00K

---272.00K

--272.00K

--47.00K

22.35%750.00K

--613.00K

Capital expenditures

----

-4.55%105.00K

-83.64%144.00K

--0.00

--272.00K

--110.00K

43.56%880.00K

--613.00K

Net cash flow from disposal of fixed assets

-1268.75%-935.00K

-108.33%-12.00K

93.01%-19.00K

-100.37%-1.00K

70.21%80.00K

-80.80%144.00K

---272.00K

--272.00K

--47.00K

22.35%750.00K

--613.00K

Net cash flow from investment products

----

481.03%21.25M

157.75%24.25M

529.42%19.02M

-17.46%14.24M

---5.58M

---41.99M

--3.02M

16528.57%17.25M

---105.00K

Cash from non-current investing activities

Net cash flow from investing activities

-95.06%935.00K

-99.91%12.00K

500.92%21.27M

157.38%24.25M

536.67%18.94M

-14.58%14.10M

---5.30M

---42.26M

--2.98M

2398.05%16.50M

---718.00K

Financing cash flow

Cash flow from continuous financing activities

----

100.00%0.00

-99.92%59.00K

81.95%-48.00K

100.00%0.00

---169.00K

--78.30M

---266.00K

-8250.00%-815.00K

--10.00K

Net cash flow from common stock issuance/repurchase

----

---179.00K

--78.02M

----

Proceeds from stock option exercised by employees

----

-100.00%0.00

1366.67%44.00K

-100.00%0.00

--10.00K

--9.00K

--3.00K

730.00%83.00K

--10.00K

Net cash flow from other financing activities

----

--0.00

-78.07%59.00K

65.80%-92.00K

100.00%0.00

--0.00

--269.00K

---269.00K

---898.00K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

----

100.00%0.00

-99.92%59.00K

81.95%-48.00K

100.00%0.00

---169.00K

--78.30M

---266.00K

-8250.00%-815.00K

--10.00K

Net cash flow

Beginning cash balance

50.96%21.96M

62.12%29.04M

-37.65%24.25M

-19.08%17.52M

-56.74%14.55M

-48.98%17.91M

--38.89M

--21.65M

--33.63M

-71.63%35.11M

--123.76M

Current period cash flow changes

-213.51%-3.37M

-110.37%-7.08M

122.85%4.79M

-60.96%6.73M

124.77%2.97M

-126.60%-3.37M

---20.98M

--17.25M

---11.98M

91.35%-1.48M

---17.16M

Ending cash balance

6.15%18.59M

50.96%21.96M

62.12%29.04M

-37.65%24.25M

-19.08%17.52M

-56.74%14.55M

--17.91M

--38.89M

--21.65M

-68.45%33.63M

--106.60M

Free cash flow

73.15%-4.30M

59.72%-7.09M

-6.27%-16.48M

7.78%-17.58M

-8.30%-16.03M

2.47%-17.60M

---15.50M

---19.06M

---14.80M

-5.75%-18.05M

---17.07M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

